Conference Coverage
Conference Coverage
SC-PEG comparable to pegaspargase in young ALL/LL patients
CHICAGO – Patients who received SC-PEG had similar serum asparaginase activity, toxicities, and survival as patients...
Conference Coverage
Low intensity bridging may be best path to CAR T in adult ALL
CHICAGO – Researchers examined the use of high- and low-intensity chemotherapy bridging for patients waiting for treatment with a CD19-directed...
Conference Coverage
Ribociclib plus endocrine therapy boosts survival of HR+/HER2- breast cancer
CHICAGO – The overall survival rate at 42 months was 70% in the combined therapy group, vs. 46% for patients treated...
Conference Coverage
Pembro with or without chemo superior to EXTREME for advanced HNSCC
CHICAGO – Pembrolizumab with and without chemotherapy proved superior for overall survival vs. the EXTREME regimen...
Conference Coverage
Short-term ADT improves radiation salvage after prostatectomy
CHICAGO – 10-year metastasis-free survival was superior for patients who received goserelin plus radiation for...
Conference Coverage
Antibodies may have role in ‘TKI world’ of EGFR-mutant NSCLC
CHICAGO – Two antibody approaches showed promising preliminary activity and manageable safety, in studies designed to address the need for new...
Conference Coverage
Combo produces ‘best response rate’ after first relapse in kids with AML
CHICAGO – CPX-351 followed by fludarabine, cytarabine, and filgrastim produced an overall response rate of 81%.
Conference Coverage
Trial matches pediatric cancer patients to targeted therapies
Nearly a quarter of the patients screened as part of the National Cancer Institute–Children’s Oncology Group Pediatric MATCH trial have been...
Conference Coverage
SEER data show that pancreatic cancer mortality rates differ by ethnicity
SAN DIEGO – Between 2013 and 2015, mortality rates began to fall among all ethnicities, for reasons that remain unclear.
Conference Coverage
Entrectinib exhibits activity in children with solid tumors
Entrectinib produced responses in patients who had fusions or mutations in target genes.
Conference Coverage
Targeted sequencing panel IDs Lynch syndrome in women with/at risk for endometrial cancer
NASHVILLE, TENN. – A targeted next-generation sequencing panel rapidly IDs Lynch syndrome pathogenic mutations in...